ClinicalTrials.Veeva

Menu

Percutaneous Cryoablation Versus Partial Nephrectomy for T1b Renal Tumor

I

I.M. Sechenov First Moscow State Medical University

Status

Enrolling

Conditions

Renal Tumor

Treatments

Procedure: Cryoablation
Procedure: Renal biopsy
Procedure: Partial nephrectomy

Study type

Interventional

Funder types

Other

Identifiers

NCT04506671
CA_vs_PN

Details and patient eligibility

About

The aim of our study is to assess the long-term oncological and functional outcomes of cryoablation for T1b renal tumors, as well as such important parameters as the patient's quality of life after treatment, and to compare the results with those after partial nephrectomy.

Enrollment

142 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

•CT-confirmed renal mass > 4 to 7 cm (T1b)

Exclusion criteria

  • Multiple renal tumors;
  • Recurrence of renal tumor;
  • Intolerance to iodine-containing contrast agents;
  • Pregnancy;
  • Patients with Bosniak 4 cysts
  • Presence of other oncological diseases;
  • Impossibility of organ-preserving treatment due to the proximity of the tumor to the vessels or the calyx-pelvic system
  • Absence of malignant pathology based on prior biopsy.

Trial design

Primary purpose

Treatment

Allocation

Non-Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

142 participants in 2 patient groups

Cryoablation group
Experimental group
Description:
Patients with T1b renal tumor and ECOQ\>20
Treatment:
Procedure: Cryoablation
Procedure: Renal biopsy
Partial nephrectomy group
Active Comparator group
Description:
Patients with T1b renal tumor
Treatment:
Procedure: Partial nephrectomy

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems